Integra LifeSciences (IART) PT Lowered to $18 at BMO Capital

July 30, 2026 9:04 AM

BMO Capital analyst Vik Chopra lowered the price target on Integra LifeSciences (NASDAQ: IART) to $18.00 (from $19.00) while maintaining a Market Perform rating.

No results found